Orgenesis Announces Collaboration with The John Hopkins University for the Development and Processing of Cell and Gene Based Clinical Therapeutics
GERMANTOWN, Md., Feb. 19, 2020 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS), a provider of point-of-care cell and gene therapy […]